Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 9.

Greenberg, J P; Sherman, J; Zweifel, S A; Chen, R W S; Duncker, T; Kohl, S; Baumann, B; Wissinger, B; Yannuzzi, L A; Tsang, S H (2014). Spectral-Domain Optical Coherence Tomography Staging and Autofluorescence Imaging in Achromatopsia. JAMA Ophthalmology, 132(4):437-445.

Knechtle, B; Baumann, B; Wirth, A; Knechtle, P; Rosemann, T (2010). Male ironman triathletes lose skeletal muscle mass. Asia Pacific Journal of Clinical Nutrition, 19(1):91-97.

Knechtle, B; Baumann, B; Knechtle, P; Wirth, A; Rosemann, T (2010). A comparison of anthropometry between Ironman triathletes and ultra-swimmers. Journal of Human Kinetics, 24:57-64.

Knechtle, B; Wirth, A; Baumann, B; Knechtle, P; Kohler, G; Rosemann, T; Senn, O (2010). An ironman triathlon does not lead to a change in body mass in female triathletes. Research in Sports Medicine, 18(2):115-126.

Knechtle, B; Wirth, A; Baumann, B; Knechtle, P; Rosemann, T (2010). Personal best time, percent body fat, and training are differently associated with race time for male and female ironman triathletes. Research Quarterly for Exercise and Sport, 81(1):62-68.

Knechtle, B; Baumann, B; Knechtle, P; Rosemann, T (2010). Speed during training and anthropometric measures in relation to race performance by male and female open-water ultra-endurance swimmers. Perceptual and Motor Skills, 111(2):463-474.

Knechtle, B; Baumann, B; Knechtle, P; Rosemann, T (2010). What influences race performance in male open-water ultra-endurance swimmers: anthropometry or training? Human Movement, 11(1):91-95.

Götzinger, E; Pircher, M; Geitzenauer, W; Ahlers, C; Baumann, B; Michels, S; Schmidt-Erfurth, U; Hitzenberger, C K (2008). Retinal pigment epithelium segmentation by polarization sensitive optical coherence tomography. Optics Express, 16(21):16410-16422.

Gautschi, O; Tschopp, S; Olie, R A; Leech, S H; Simoes-Wust, A P; Ziegler, A; Baumann, B; Odermatt, B; Hall, J; Stahel, R A; Zangemeister-Wittke, U (2001). Activity of a Novel bcl-2/bcl-xL-Bispecific Antisense Oligonucleotide Against Tumors of Diverse Histologic Origins. Journal of the National Cancer Institute, 93(6):463-471.

This list was generated on Wed Jun 26 20:22:25 2019 CEST.